Circulating tumor cell clusters: What we know and what we expect (Review)
- Authors:
- Yupeng Hong
- Francia Fang
- Qi Zhang
-
Affiliations: Department of Oncology, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China, Trinity College of Arts and Sciences, Duke University, Durham, NC 27710, USA, Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China - Published online on: October 24, 2016 https://doi.org/10.3892/ijo.2016.3747
- Pages: 2206-2216
-
Copyright: © Hong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Krebs MG, Metcalf RL, Carter L, Brady G, Blackhall FH and Dive C: Molecular analysis of circulating tumour cells - biology and biomarkers. Nat Rev Clin Oncol. 11:129–144. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lianidou ES: Circulating tumor cell isolation: A marathon race worth running. Clin Chem. 60:287–289. 2014. View Article : Google Scholar | |
|
Plaks V, Koopman CD and Werb Z: Cancer. Circulating tumor cells. Science. 341:1186–1188. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, et al: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ and Raghavan D: Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 14:6302–6309. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, et al: Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol. 26:3213–3221. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Cristofanilli M: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Semin Oncol. 33(Suppl 9): S9–S14. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, et al: EMT and dissemination precede pancreatic tumor formation. Cell. 148:349–361. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Hou JM, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK, Priest LJ, Greystoke A, Zhou C, Morris K, et al: Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol. 30:525–532. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Fidler IJ: The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur J Cancer. 9:223–227. 1973. View Article : Google Scholar : PubMed/NCBI | |
|
Lione A and Bosmann HB: Quantitative relationship between volume of tumour cell units and their intravascular survival. Br J Cancer. 37:248–253. 1978. View Article : Google Scholar : PubMed/NCBI | |
|
Liotta LA, Kleinerman J and Saidel GM: Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res. 34:997–1004. 1974.PubMed/NCBI | |
|
Liotta LA, Saidel MG and Kleinerman J: The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res. 36:889–894. 1976.PubMed/NCBI | |
|
Thompson SC: The colony forming efficiency of single cells and cell aggregates from a spontaneous mouse mammary tumour using the lung colony assay. Br J Cancer. 30:332–336. 1974. View Article : Google Scholar : PubMed/NCBI | |
|
Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, et al: Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 158:1110–1122. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Chen JF, Ho H, Lichterman J, Lu YT, Zhang Y, Garcia MA, Chen SF, Liang AJ, Hodara E, Zhau HE, et al: Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases. Cancer. 121:3240–3251. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
de Wit S, van Dalum G, Lenferink AT, Tibbe AG, Hiltermann TJ, Groen HJ, van Rijn CJ and Terstappen LW: The detection of EpCAM(+) and EpCAM(−) circulating tumor cells. Sci Rep. 5:122702015. View Article : Google Scholar | |
|
Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, et al: Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res. 10:8152–8162. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Watanabe S: The metastasizability of tumor cells. Cancer. 7:215–223. 1954. View Article : Google Scholar : PubMed/NCBI | |
|
Garvie WH and Matheson AB: The effect of intravenous fluids on the development on experimental tumour metastases: Their effect on tumour cell aggregation. Br J Cancer. 20:838–846. 1966. View Article : Google Scholar : PubMed/NCBI | |
|
Topal B, Roskams T, Fevery J and Penninckx F: Aggregated colon cancer cells have a higher metastatic efficiency in the liver compared with nonaggregated cells: An experimental study. J Surg Res. 112:31–37. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Knisely WH and Mahaley MS Jr: Relationship between size and distribution of spontaneous metastases and three sizes of intravenously injected particles of VX2 carcinoma. Cancer Res. 18:900–905. 1958.PubMed/NCBI | |
|
Peeters DJ, Brouwer A, Van den Eynden GG, Rutten A, Onstenk W, Sieuwerts AM, Van Laere SJ, Huget P, Pauwels P, Peeters M, et al: Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancer. Cancer Lett. 356B:872–879. 2015. View Article : Google Scholar | |
|
Glaves D: Correlation between circulating cancer cells and incidence of metastases. Br J Cancer. 48:665–673. 1983. View Article : Google Scholar : PubMed/NCBI | |
|
Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA, Rothenberg SM, Shah AM, Smas ME, Korir GK, et al: Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci USA. 107:18392–18397. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Duda DG, Duyverman AM, Kohno M, Snuderl M, Steller EJ, Fukumura D and Jain RK: Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci USA. 107:21677–21682. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Upreti M, Jamshidi-Parsian A, Koonce NA, Webber JS, Sharma SK, Asea AA, Mader MJ and Griffin RJ: Tumor-endothelial cell three-dimensional spheroids: New aspects to enhance radiation and drug therapeutics. Transl Oncol. 4:365–376. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hou JM, Krebs M, Ward T, Sloane R, Priest L, Hughes A, Clack G, Ranson M, Blackhall F and Dive C: Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol. 178:989–996. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Friedlander TW, Ngo VT, Dong H, Premasekharan G, Weinberg V, Doty S, Zhao Q, Gilbert EG, Ryan CJ, Chen WT, et al: Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer. Int J Cancer. 134:2284–2293. 2014. View Article : Google Scholar | |
|
Balasubramanian P, Lang JC, Jatana KR, Miller B, Ozer E, Old M, Schuller DE, Agrawal A, Teknos TN, Summers TA Jr, et al: Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck. PLoS One. 7:e420482012. View Article : Google Scholar : PubMed/NCBI | |
|
Brandt B, Junker R, Griwatz C, Heidl S, Brinkmann O, Semjonow A, Assmann G and Zänker KS: Isolation of prostate-derived single cells and cell clusters from human peripheral blood. Cancer Res. 56:4556–4561. 1996.PubMed/NCBI | |
|
Molnar B, Ladanyi A, Tanko L, Sréter L and Tulassay Z: Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin Cancer Res. 7:4080–4085. 2001.PubMed/NCBI | |
|
Wang ZP, Eisenberger MA, Carducci MA, Partin AW, Scher HI and Ts'o PO: Identification and characterization of circulating prostate carcinoma cells. Cancer. 88:2787–2795. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Sarioglu AF, Aceto N, Kojic N, Donaldson MC, Zeinali M, Hamza B, Engstrom A, Zhu H, Sundaresan TK, Miyamoto DT, et al: A microfluidic device for label-free, physical capture of circulating tumor cell clusters. Nat Methods. 12:685–691. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schütze K, Capron F, Franco D, Pazzagli M, Vekemans M, et al: Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulating tumor cells. Am J Pathol. 156:57–63. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Vona G, Estepa L, Béroud C, Damotte D, Capron F, Nalpas B, Mineur A, Franco D, Lacour B, Pol S, et al: Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology. 39:792–797. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Krebs MG, Hou JM, Sloane R, Lancashire L, Priest L, Nonaka D, Ward TH, Backen A, Clack G, Hughes A, et al: Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol. 7:306–315. 2012. View Article : Google Scholar | |
|
Adams AA, Okagbare PI, Feng J, Hupert ML, Patterson D, Göttert J, McCarley RL, Nikitopoulos D, Murphy MC and Soper SA: Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor. J Am Chem Soc. 130:8633–8641. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Gleghorn JP, Pratt ED, Denning D, Liu H, Bander NH, Tagawa ST, Nanus DM, Giannakakou PA and Kirby BJ: Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody. Lab Chip. 10:27–29. 2010. View Article : Google Scholar | |
|
Mohamed H, Murray M, Turner JN and Caggana M: Isolation of tumor cells using size and deformation. J Chromatogr A. 1216:8289–8295. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Tan SJ, Yobas L, Lee GY, Ong CN and Lim CT: Microdevice for the isolation and enumeration of cancer cells from blood. Biomed Microdevices. 11:883–892. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Y, Phillips JA, Yan J, Li Q, Fan ZH and Tan W: Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells. Anal Chem. 81:7436–7442. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng S, Lin H, Liu JQ, Balic M, Datar R, Cote RJ and Tai YC: Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A. 1162:154–161. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Hou HW, Warkiani ME, Khoo BL, Li ZR, Soo RA, Tan DS, Lim WT, Han J, Bhagat AA and Lim CT: Isolation and retrieval of circulating tumor cells using centrifugal forces. Sci Rep. 3:12592013. View Article : Google Scholar : PubMed/NCBI | |
|
Harouaka RA, Zhou MD, Yeh YT, Khan WJ, Das A, Liu X, Christ CC, Dicker DT, Baney TS, Kaifi JT, et al: Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells. Clin Chem. 60:323–333. 2014. View Article : Google Scholar | |
|
Cho EH, Wendel M, Luttgen M, Yoshioka C, Marrinucci D, Lazar D, Schram E, Nieva J, Bazhenova L, Morgan A, et al: Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys Biol. 9:0160012012. View Article : Google Scholar : PubMed/NCBI | |
|
Ge F, Zhang H, Wang DD, Li L and Lin PP: Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells. Oncotarget. 6:27049–27064. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Wang F, Ning N, Chen Q, Yang Z, Guo Y, Xu D, Zhang D, Zhan T and Cui W: Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer. Int J Cancer. 136:1228–1233. 2015. View Article : Google Scholar | |
|
Zamay GS, Kolovskaya OS, Zamay TN, Glazyrin YE, Krat AV, Zubkova O, Spivak E, Wehbe M, Gargaun A, Muharemagic D, et al: Aptamers selected to postoperative lung adenocarcinoma detect circulating tumor cells in human blood. Mol Ther. 23:1486–1496. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
King MR, Phillips KG, Mitrugno A, Lee TR, de Guillebon AM, Chandrasekaran S, McGuire MJ, Carr RT, Baker-Groberg SM, Rigg RA, et al: A physical sciences network characterization of circulating tumor cell aggregate transport. Am J Physiol Cell Physiol. 308:C792–C802. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Cheung KJ, Padmanaban V, Silvestri V, Schipper K, Cohen JD, Fairchild AN, Gorin MA, Verdone JE, Pienta KJ, Bader JS, et al: Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters. Proc Natl Acad Sci USA. 113:E854–E863. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Glinsky VV, Glinsky GV, Glinskii OV, Huxley VH, Turk JR, Mossine VV, Deutscher SL, Pienta KJ and Quinn TP: Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res. 63:3805–3811. 2003.PubMed/NCBI | |
|
Geng Y, Chandrasekaran S, Hsu JW, Gidwani M, Hughes AD and King MR: Phenotypic switch in blood: Effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesion. PLoS One. 8:e549592013. View Article : Google Scholar : PubMed/NCBI | |
|
Fidler IJ: Immune stimulation-inhibition of experimental cancer metastasis. Cancer Res. 34:491–498. 1974.PubMed/NCBI | |
|
Gasic GJ, Gasic TB, Galanti N, Johnson T and Murphy S: Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer. 11:704–718. 1973. View Article : Google Scholar : PubMed/NCBI | |
|
Läubli H, Stevenson JL, Varki A, Varki NM and Borsig L: L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest. Cancer Res. 66:1536–1542. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Küsters B, Kats G, Roodink I, Verrijp K, Wesseling P, Ruiter DJ, de Waal RM and Leenders WP: Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis. Oncogene. 26:5808–5815. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Borsig L, Wong R, Hynes RO, Varki NM and Varki A: Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA. 99:2193–2198. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Molnar B, Floro L, Sipos F, Toth B, Sreter L and Tulassay Z: Elevation in peripheral blood circulating tumor cell number correlates with macroscopic progression in UICC stage IV colorectal cancer patients. Dis Markers. 24:141–150. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Sugino T, Kusakabe T, Hoshi N, Yamaguchi T, Kawaguchi T, Goodison S, Sekimata M, Homma Y and Suzuki T: An invasion-independent pathway of blood-borne metastasis: A new murine mammary tumor model. Am J Pathol. 160:1973–1980. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Ao Z, Shah SH, Machlin LM, Parajuli R, Miller PC, Rawal S, Williams AJ, Cote RJ, Lippman ME, Datar RH, et al: Identification of cancer-associated fibroblasts in circulating blood from patients with metastatic breast cancer. Cancer Res. 75:4681–4687. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, et al: Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. 339:580–584. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma D, Brummel-Ziedins KE, Bouchard BA and Holmes CE: Platelets in tumor progression: A host factor that offers multiple potential targets in the treatment of cancer. J Cell Physiol. 229:1005–1015. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lecharpentier A, Vielh P, Perez-Moreno P, Planchard D, Soria JC and Farace F: Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br J Cancer. 105:1338–1341. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Maddipati R and Stanger BZ: Pancreatic cancer metastases harbor evidence of polyclonality. Cancer Discov. 5:1086–1097. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Au SH, Storey BD, Moore JC, Tang Q, Chen YL, Javaid S, Sarioglu AF, Sullivan R, Madden MW, O'Keefe R, et al: Clusters of circulating tumor cells traverse capillary-sized vessels. Proc Natl Acad Sci USA. 113:4947–4952. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Fidler IJ and Talmadge JE: Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Cancer Res. 46:5167–5171. 1986.PubMed/NCBI | |
|
Zhao Q, Barclay M, Hilkens J, Guo X, Barrow H, Rhodes JM and Yu LG: Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. Mol Cancer. 9:1542010. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao Q, Guo X, Nash GB, Stone PC, Hilkens J, Rhodes JM and Yu LG: Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. Cancer Res. 69:6799–6806. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Yu LG, Andrews N, Zhao Q, McKean D, Williams JF, Connor LJ, Gerasimenko OV, Hilkens J, Hirabayashi J, Kasai K, et al: Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J Biol Chem. 282:773–781. 2007. View Article : Google Scholar | |
|
Labelle M, Begum S and Hynes RO: Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 20:576–590. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wels J, Kaplan RN, Rafii S and Lyden D: Migratory neighbors and distant invaders: Tumor-associated niche cells. Genes Dev. 22:559–574. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Psaila B and Lyden D: The metastatic niche: Adapting the foreign soil. Nat Rev Cancer. 9:285–293. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Phillips KG, Lee AM, Tormoen GW, Rigg RA, Kolatkar A, Luttgen M, Bethel K, Bazhenova L, Kuhn P, Newton P, et al: The thrombotic potential of circulating tumor microemboli: Computational modeling of circulating tumor cell-induced coagulation. Am J Physiol Cell Physiol. 308:C229–C236. 2015. View Article : Google Scholar : | |
|
Denes V, Lakk M, Makarovskiy A, Jakso P, Szappanos S, Graf L, Mandel L, Karadi I and Geck P: Metastasis blood test by flow cytometry: In vivo cancer spheroids and the role of hypoxia. Int J Cancer. 136:1528–1536. 2015. View Article : Google Scholar | |
|
Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A and Muschel RJ: Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: A new model for metastasis. Nat Med. 6:100–102. 2000. View Article : Google Scholar | |
|
Mu Z, Wang C, Ye Z, Austin L, Civan J, Hyslop T, Palazzo JP, Jaslow R, Li B, Myers RE, et al: Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer. Breast Cancer Res Treat. 154:563–571. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Jansson S, Bendahl PO, Larsson AM, Aaltonen KE and Rydén L: Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort. BMC Cancer. 16:4332016. View Article : Google Scholar : PubMed/NCBI | |
|
Mascalchi M, Falchini M, Maddau C, Salvianti F, Nistri M, Bertelli E, Sali L, Zuccherelli S, Vella A, Matucci M, et al: Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC. J Cancer Res Clin Oncol. 142:195–200. 2016. View Article : Google Scholar | |
|
Giesing M, Suchy B, Driesel G and Molitor D: Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4–10 ng/ml and disease prognostication after radical prostatectomy. BJU Int. 105:1000–1010. 2010. View Article : Google Scholar | |
|
Choi JW, Kim JK, Yang YJ, Kim P, Yoon KH and Yun SH: Urokinase exerts antimetastatic effects by dissociating clusters of circulating tumor cells. Cancer Res. 75:4474–4482. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wendel M, Bazhenova L, Boshuizen R, Kolatkar A, Honnatti M, Cho EH, Marrinucci D, Sandhu A, Perricone A, Thistlethwaite P, et al: Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: A glimpse into lung cancer biology. Phys Biol. 9:0160052012. View Article : Google Scholar : PubMed/NCBI | |
|
Reddy RM, Murlidhar V, Zhao L, Grabauskiene S, Zhang Z, Ramnath N, Lin J, Chang AC, Carrott P, Lynch W, et al: Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer. J Thorac Cardiovasc Surg. 151:852–857. 2016. View Article : Google Scholar | |
|
Kats-Ugurlu G, Roodink I, de Weijert M, Tiemessen D, Maass C, Verrijp K, van der Laak J, de Waal R, Mulders P, Oosterwijk E, et al: Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma. J Pathol. 219:287–293. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Loh J, Jovanovic L, Lehman M, Capp A, Pryor D, Harris M, Nelson C and Martin J: Circulating tumor cell detection in high-risk non-metastatic prostate cancer. J Cancer Res Clin Oncol. 140:2157–2162. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Chang MC, Chang YT, Chen JY, Jeng YM, Yang CY, Tien YW, Yang SH, Chen HL, Liang TY, Wang CF, et al: Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma. Clin Chem. 62:505–513. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Long E, Ilie M, Bence C, Butori C, Selva E, Lalvée S, Bonnetaud C, Poissonnet G, Lacour JP, Bahadoran P, et al: High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness. Cancer Med. 5:1022–1030. 2016. View Article : Google Scholar : PubMed/NCBI |
